CAROL VINCENT: Open Payments
NPI 1295341170 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,877 in 62 payments from 17 companies in 2025. Trend: 2023 $419 · 2024 $1,151 · 2025 $1,877
Food & beverage: $1,877
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $434 |
| ABBVIE INC. | 5 | $316 |
| Novo Nordisk Inc | 11 | $227 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $217 |
| Phathom Pharmaceuticals, Inc. | 5 | $184 |
| Amgen Inc. | 6 | $119 |
| PFIZER INC. | 3 | $64 |
| Exact Sciences Corporation | 2 | $58 |
| Esperion Therapeutics, Inc. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
Products named: FARXIGA, VRAYLAR, CAPLYTA, VOQUEZNA, Ozempic, AIRSUPRA, OTEZLA, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
